Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer
Breast Cancer Research and Treatment · 2024
DOI: 10.1007/s10549-024-07342-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Kirin Saint und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan Medical School, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Breast Neoplasms, Cancer Survivors, Exercise. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect of neurotoxic chemotherapy. Exercise activates neuromuscular function and may improve CIPN. We examined the association between exercise and CIPN symptoms in breast cancer survivors. METHODS: In a retrospective cross-sectional study, we included patients completing a survey assessing exercise exposure and neuropathy symptoms in a tertiary cancer center survivorship clinic. We evaluated exercise duration and intensity using a standardized questionnaire quantified in metabolic equivalent tasks (MET-h/wk). We defined exercisers as patients meeting the National Physical Activity Guidelines' criteria. We used multivariable logistic regressions to examine the relationship between exercise and CIPN and if this differed as a function of chemotherapy regimen adjusting for age, gender, and race. RESULTS: We identified 5444 breast cancer survivors post-chemotherapy (median age 62 years (interquartile range [IQR]: 55, 71); median 4.7 years post-chemotherapy (IQR: 3.3, 7.6)) from 2017 to 2022. CIPN overall prevalence was 34% (95% confidence interval [CI]: 33%, 36%), 33% for non-taxane, and 37% for taxane-based chemotherapy. CIPN prevalence was 28% (95% CI: 26%, 30%) among exercisers and 38% (95% CI: 37%, 40%) among non-exercisers (difference 11%; 95% CI: 8%, 13%; p 20.25 MET-h/wk) levels of exercise reported CIPN. Exercise was associated with reduced prevalence of all CIPN symptoms regardless of chemotherapy type. CONCLUSION: CIPN may persist several years following chemotherapy among patients with breast cancer but is significantly reduced by exercise in a dose-dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Michigan Medical School, Ann Arbor, MI, USA.
- Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Stony Brook University, Stony Brook, NY, USA.
- Dana-Farber Cancer Institute, Boston, MA, USA.
- Stockton University, Galloway, NJ, USA.
- University of Witwatersrand, Johannesburg, South Africa.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Saint, K., Nemirovsky, D., Lessing, A., Chen, Y., Yang, M., Underwood, W. P., Galantino, M. L., Jones, L. W., & Bao, T. (2024). Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07342-6
Vancouver
Saint K, Nemirovsky D, Lessing A, Chen Y, Yang M, Underwood WP, et al. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07342-6
BibTeX
@article{Saint2024,
author = {Saint, Kirin and Nemirovsky, David and Lessing, Alexie and Chen, Yuan and Yang, Mingxiao and Underwood, Whitney P and Galantino, Mary Lou and Jones, Lee W and Bao, Ting},
title = {Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer},
journal = {Breast Cancer Research and Treatment},
year = {2024},
doi = {10.1007/s10549-024-07342-6}
}
EUVIMED